GTS Securities’s Bio-Techne TECH Stock Holding History

GTS Securities’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-4,107	Closed	-$296K	–	1572
2024 Q4	$296K	Buy	4,107 +859	+26%	+$63.1K	0.01%	886
2024 Q3	$260K	Buy	+3,248	New	+$244K	﹤0.01%	3424

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

GTS Securities's TECH Position: Q1 2025 in Review

GTS Securities sold out of Bio-Techne (TECH) in Q1 2025, closing a stake of 4,107 shares — an estimated $296K sold.

GTS Securities first reported a position in TECH in Q3 2024 and held it in 2 quarters. The position peaked at $296K in Q4 2024. 577 funds tracked by Wall St. Rank hold TECH as of Q1 2025.

GTS Securities reported no remaining Bio-Techne position as of Q1 2025 after selling out during the quarter.
GTS Securities sold 4,107 Bio-Techne shares in Q1 2025, an estimated $296K.
GTS Securities first reported a position in Bio-Techne in Q3 2024 and held it in 2 quarters.
GTS Securities's Bio-Techne position peaked at $296K in Q4 2024.
577 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2025.

Based on GTS Securities's 13F filing for Q1 2025, filed 15 May 2025.